Exabis Library
Welcome to the e-CCO Library!
P321: Cessation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Patient Data Meta-Analysis of 323 patients from 12 studies
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P321: Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P321: Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P321: Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remission
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P321: Ulcerative colitis: Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting disease severity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P322: A change in ΔMCV predicts mucosal healing in patients with Crohn's disease under combination therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P322: Complications to parenteral therapy in patients with intestinal failure because of inflammatory bowel disease: A retrospective cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P322: Disease-related worries and concerns in patients with ulcerative colitis: 1-year data from ICONIC
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P322: Effectiveness of Tumor Necrosis Factor-alpha inhibitors and Thiopurines combination therapy according to 6-thioguanine nucleotides plasma levels: A Systematic Review.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P322: Hepatitis B reactivation under biologic therapy in patients with HBsAg negative phase of chronic HBV infection
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P322: High body mass index and anaemia at diagnosis are predictors of extra-intestinal manifestations in children with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P322: Mycobiome signature in pediatric patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P323 Successful validation of the quantum blue quantitative rapid test to monitor C-reactive protein in capillary blood of patients suffering from chronic inflammatory diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P323: Efficacy and safety of tofacitinib treatment for one year in Japanese patients with Ulcerative Colitis in a specialized Inflammatory Bowel Disease center
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P323: Fatty liver assessment in inflammatory bowel disease patients using controlled attenuation parameter
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P323: Prevalence of vitamin D deficiency in patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P323: Prognostic factors for long-term adalimumab treatment
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P323: The Crohn's Disease Exclusion Diet (CDED) for pouch inflammation: an interventional pilot study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM